Article
18 May 2026
The DTSA Turns Ten: What A Decade Of Litigation Tells Us
AUTHORS CONTENT
Article
16 Jan 2026
Trade Secrets: A Guide For Business
Article
29 May 2023
Déjà Vu: The Supreme Court Ignores The Solicitor General's Invitation To Revisit Section 101 . . . Again.
Article
10 Sep 2019
Federal Circuit Improves The Short-Term "Forecast" For The Doctrine Of Equivalents
Article
20 Jun 2017
Supreme Court Limits Patent Owners' Ability To Control Post-Sale Use Of Patented Products
Article
31 Mar 2017
Supreme Court Holds Equitable Laches Is No Longer Available To Limit Patent Damages
Article
17 Mar 2017
Janssen V. Celltrion: A Misstep In The BPCIA Patent Dance
Article
10 Mar 2017
Limiting Extraterritorial Reach Of U.S. Patents: "Substantial" Means More Than One
Article
10 Mar 2017
Limiting Extraterritorial Reach Of U.S. Patents: "Substantial" Means More Than One
Article
13 Jul 2016
Federal Circuit Offers Path Through Section 101 Thicket For Biotech Method Patents
Article
12 Jul 2016
Federal Circuit Invites FDA's Early Licensure Of Biosimilars To Encourage Pre-Launch Resolution Of Patent Disputes
Article
29 Jun 2016
Supreme Court Defers To The Patent Office On Institution And Management Of Post-Grant Proceedings
Article
28 Jun 2016
Objective Reasonableness Can Be Central To Fee-Shifting Analysis In Copyright Cases
Article
09 May 2016
Federal Circuit Denies TC Heartland's Petition To Change The Venue Standard, Renewing Interest In Congressional Venue Reform
Article
27 Jul 2015
A Fractured Federal Circuit Panel Interprets The Biosimilars Patent Resolution Procedures
Article
26 Feb 2015
Divided Federal Circuit Panel Upholds Patent Office’s "Broadest Reasonable Interpretation" Standard For Construing Claims In Post-Grant Review
Article
02 Feb 2015
Supreme Court Calls For Greater Deference To District Court Claim Construction
Article
30 Dec 2014
Federal Circuit’s Sandoz v. Amgen Decision Forecloses Early Declaratory
Article
30 Dec 2014
Federal Circuit’s Sandoz v. Amgen Decision Forecloses Early Declaratory Judgment Suits By Biosimilars Applicants
Article
03 Jul 2014
What Did The Court Really Say About Patent Eligibility?